GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Matricelf MTLF.TA · ILA

Health Care · Tel Aviv · 🇮🇱 Israel

Compare

240.50

-0.08%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in ILS, from our data supplier.

FY2025

Net income

−ILS 27.8m

FY2019FY2025

Free cash flow

−ILS 15.3m

FY2019FY2025

Shareholders' equity

ILS 10.1m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross profit−ILS 1.0m−ILS 272−ILS 255−ILS 811,000−ILS 810,000−ILS 68,558−ILS 299
Research and developmentILS 11.9mILS 11,714ILS 10,589ILS 8.3mILS 7.4mILS 2.8mILS 1.3m
Operating income−ILS 18.3m−ILS 16,113−ILS 14,730−ILS 12.6m−ILS 16.1m−ILS 4.2m−ILS 1.5m
Net income−ILS 27.8m−ILS 15,582−ILS 13,831−ILS 12.5m−ILS 16.3m−ILS 4.3m−ILS 1.1m
Diluted earnings per share-1.42-0.00-0.00-0.88-1.35-0.14-0.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsILS 27.9mILS 18.4mILS 30.2mILS 39.5mILS 28.9mILS 5.9mILS 4.2m
Cash and short-term investmentsILS 21.8mILS 11.9mILS 23.6mILS 33.2mILS 22.4mILS 1.8mILS 1.7m
Total liabilitiesILS 17.8mILS 3.2mILS 3.4mILS 3.7mILS 2.7mILS 3.1mILS 591,269
DebtILS 800,000ILS 1.3mILS 1.5mILS 1.2mILS 1.5mILS 2.1m—
Shareholders' equityILS 10.1mILS 15.2mILS 26.8mILS 35.8mILS 26.2mILS 2.8mILS 3.6m
Shares outstanding20m16m16m14m12m30m30m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−ILS 14.7m−ILS 11,754−ILS 10,487−ILS 8.3m−ILS 6.6m−ILS 3.5m−ILS 307,796
Capital spending−ILS 597,000−ILS 243−ILS 616−ILS 602,000−ILS 2.4m−ILS 337,966−ILS 36,309
Free cash flow−ILS 15.3m−ILS 11,997−ILS 11,103−ILS 8.9m−ILS 9.0m−ILS 3.8m−ILS 344,105

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Jun 2024
Gross profit−ILS 1.0m—−ILS 509,000−ILS 289,000−ILS 496,000—−ILS 492,000−ILS 496,000
Operating income−ILS 18.7m−ILS 9.4m−ILS 8.8m−ILS 4.4m−ILS 4.8m−ILS 4.8m−ILS 8.8m−ILS 7.3m
Net income−ILS 7.7m−ILS 3.8m−ILS 18.3m−ILS 9.1m−ILS 4.8m−ILS 4.8m−ILS 8.6m−ILS 7.0m
Diluted earnings per share-0.25-0.13-0.94-0.47-0.24-0.24-0.53-0.43
Cash from operations−ILS 8.0m−ILS 4.0m−ILS 6.0m−ILS 3.0m−ILS 8.0m—−ILS 6.0m−ILS 4.0m
Total assetsILS 26.2mILS 26.2mILS 27.9mILS 27.9mILS 10,991ILS 10,991ILS 18.4mILS 24.7m
Cash and short-term investmentsILS 16.2mILS 16.0mILS 21.8mILS 20.9mILS 5,295ILS 5,295ILS 12.0mILS 18.4m
DebtILS 1.8mILS 1.8mILS 421,000ILS 421,000ILS 484,484ILS 484ILS 457,000ILS 376,000
Shareholders' equityILS 16.4mILS 16.4mILS 10.1mILS 10.1mILS 8,295ILS 8,295ILS 15.2mILS 21.6m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income13.3%34.0%—
Net income30.6%45.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-3.9-3801.5-4847.2-5.1-6.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.